Search

everythinglearnresearchcommunity

for

Search:↓

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Menopause affects hair and skin; more research needed for treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Bicalutamide improves hair density in women safely.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.